Gurmeet Chadha suggests that with corporate profitability nearing all-time highs and markets at 21 times forward earnings, investors should temper return expectations. He recommends a balanced portfolio with long-dated bonds and gold. Rural demand is showing signs of recovery, while the pharma sector, particularly CDMO and generics, presents opportunities with lower correlation to the Nifty.
NTPC Q1 Results: Cons PAT rises 11% YoY to Rs 6,108 crore, revenue falls 3%
NTPC reported an 11% YoY rise in Q1FY26 net profit to Rs 6,108 crore, despite a 3% decline in revenue. Profit and revenue fell sequentially.